• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Intraperitoneal antineoplastic agents for tumors principally confined to the peritoneal cavity.

作者信息

Markman M

出版信息

Cancer Treat Rev. 1986 Dec;13(4):219-42. doi: 10.1016/0305-7372(86)90007-1.

DOI:10.1016/0305-7372(86)90007-1
PMID:3545463
Abstract
摘要

相似文献

1
Intraperitoneal antineoplastic agents for tumors principally confined to the peritoneal cavity.
Cancer Treat Rev. 1986 Dec;13(4):219-42. doi: 10.1016/0305-7372(86)90007-1.
2
Intraperitoneal therapy for treatment of malignant disease principally confined to the peritoneal cavity.
Crit Rev Oncol Hematol. 1993 Feb;14(1):15-28. doi: 10.1016/1040-8428(93)90003-m.
3
The routinization of intraperitoneal (intracavitary) chemotherapy and immunotherapy.
Cancer Invest. 1986;4(1):29-42. doi: 10.3109/07357908609039825.
4
Intraperitoneal chemotherapy for malignant peritoneal mesothelioma.恶性腹膜间皮瘤的腹腔内化疗
Eur J Cancer. 1991;27(6):732-4. doi: 10.1016/0277-5379(91)90176-e.
5
[Intraperitoneal Chemotherapy for Peritoneal Metastasis of Gastric Cancer].[胃癌腹膜转移的腹腔内化疗]
Gan To Kagaku Ryoho. 2016 Dec;43(13):2481-2485.
6
Intracavitary chemotherapy for malignant disease confined to body cavities.腔内化疗用于局限于体腔的恶性疾病。
West J Med. 1985 Mar;142(3):364-8.
7
Combination intraperitoneal chemotherapy with cisplatin, cytarabine, and doxorubicin for refractory ovarian carcinoma and other malignancies principally confined to the peritoneal cavity.顺铂、阿糖胞苷和多柔比星联合腹腔内化疗用于治疗难治性卵巢癌及其他主要局限于腹腔的恶性肿瘤。
J Clin Oncol. 1984 Dec;2(12):1321-6. doi: 10.1200/JCO.1984.2.12.1321.
8
Intraperitoneal chemotherapy with high-dose cisplatin and cytosine arabinoside for refractory ovarian carcinoma and other malignancies principally involving the peritoneal cavity.采用大剂量顺铂和阿糖胞苷进行腹腔内化疗治疗难治性卵巢癌及其他主要累及腹腔的恶性肿瘤。
J Clin Oncol. 1985 Jul;3(7):925-31. doi: 10.1200/JCO.1985.3.7.925.
9
Intraperitoneal chemotherapy for ovarian carcinoma.卵巢癌的腹腔内化疗
Biomed Pharmacother. 1987;41(8):420-4.
10
Combination intraperitoneal chemotherapy.
J Clin Oncol. 1985 Aug;3(8):1155-7. doi: 10.1200/JCO.1985.3.8.1155.

引用本文的文献

1
Intraperitoneal chemotherapy for ovarian cancer with peritoneal metastases, systematic review of the literature and focused personal experience.用于治疗伴有腹膜转移的卵巢癌的腹腔内化疗：文献系统综述及个人经验总结
J Gastrointest Oncol. 2021 Apr;12(Suppl 1):S144-S181. doi: 10.21037/jgo-2020-06.
2
Anticancer activity of the intraperitoneal-delivered DFP-10825, the cationic liposome-conjugated RNAi molecule targeting thymidylate synthase, on peritoneal disseminated ovarian cancer xenograft model.腹腔注射DFP-10825（一种靶向胸苷酸合成酶的阳离子脂质体偶联RNAi分子）对腹膜播散性卵巢癌异种移植模型的抗癌活性。
Drug Des Devel Ther. 2018 Mar 29;12:673-683. doi: 10.2147/DDDT.S156635. eCollection 2018.
3
Inhibition of nuclear factor-κB enhances the antitumor effect of paclitaxel against gastric cancer with peritoneal dissemination in mice.
核因子-κB 的抑制增强了紫杉醇对小鼠伴有腹膜转移胃癌的抗肿瘤作用。
Dig Dis Sci. 2013 Jan;58(1):123-31. doi: 10.1007/s10620-012-2311-4. Epub 2012 Jul 18.
4
Historical progress in the initial management of ovarian cancer: intraperitoneal chemotherapy.卵巢癌初始治疗的历史进展：腹腔化疗
Curr Oncol Rep. 2006 Nov;8(6):455-64. doi: 10.1007/s11912-006-0075-8.
5
Pharmacokinetic study of paclitaxel in malignant ascites from advanced gastric cancer patients.紫杉醇在晚期胃癌患者恶性腹水中的药代动力学研究。
World J Gastroenterol. 2006 Mar 7;12(9):1412-5. doi: 10.3748/wjg.v12.i9.1412.
6
Percutaneous placement of peritoneal port-catheter in oncologic patients.
Eur Radiol. 2004 Nov;14(11):2020-4. doi: 10.1007/s00330-004-2367-4. Epub 2004 Jun 18.
7
Successful local regional therapy with topotecan of intraperitoneally growing human ovarian carcinoma xenografts.拓扑替康对腹腔内生长的人卵巢癌异种移植瘤进行成功的局部区域治疗。
Br J Cancer. 1995 Mar;71(3):525-8. doi: 10.1038/bjc.1995.104.
8
Intraperitoneal therapy in the management of ovarian carcinoma.卵巢癌治疗中的腹腔内治疗
Yale J Biol Med. 1989 Jul-Aug;62(4):393-403.
9
Impact of laparotomy finding of significant intraabdominal adhesions on the surgically defined complete response rate to subsequent salvage intraperitoneal chemotherapy.
J Cancer Res Clin Oncol. 1992;118(2):163-5. doi: 10.1007/BF01187507.
10
Intestinal obstruction due to diffuse peritoneal fibrosis at 2 years after the successful treatment of malignant peritoneal mesothelioma with intraperitoneal mitoxantrone.
Cancer Chemother Pharmacol. 1992;29(5):405-8. doi: 10.1007/BF00686012.